Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Poll|August 14, 2013
Spot Alert
Dog Named Spot?-or Baby It's Cold Outside?
Advertisement
After 6 weeks of coping with itchy lesions on her arms and legs, a 43-year-old woman seeks medical advice. The rash first erupted with the onset of cold weather. The patient recently acquired a dog.
Your differential diagnosis includes which of the following?
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Advertisement
Advertisement
Trending on Patient Care Online
1
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
2
Why Real-World Evidence Matters for Nonhormonal Menopause VMS Therapy
3
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
4
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
5